NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2025
Back to search
Official data from USPTO
OXB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
40, 42
Filing date
06/24/2024
Registration date
12/09/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/09/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
84
Owner location
Oxford, GB
Examiner
RYAN, KELLY MARIE
Law office
M20
Current location
INTENT TO USE SECTION
Holders and representatives
Holders
Oxford BioMedica plc
Representatives
Rebeccah Gan MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom and contract manufacture of products relating to biotechnology, namely, gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products, viral and non-viral vectors, and vaccines
Class 42
Biotechnology research and laboratory analytic and diagnostic services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; design of biotechnology manufacturing facilities; quality control and validation services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector and analytic assay development for others; laboratory services for biomanufacturing; research and development services for bio-manufacturing; genetic engineering laboratories and biochemistry laboratories; scientific and technological services and research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; industrial analysis services in the field of biotechnology; provision of information relating to scientific research; providing scientific information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; research and scientific analysis relating to drug discovery and development for others; scientific research and technology advisory services; scientific research and technology consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; advisory services relating to scientific and clinical research; biological research; providing clinical and medical research information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; clinical research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; Scientific research in the nature of conducting clinical trials for others; bio-manufacturing development services
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
11/19/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/19/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/09/2025
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
09/09/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/24/2025
PUBO
PUBLISHED FOR OPPOSITION
06/24/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/18/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/22/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
04/22/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/22/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
04/22/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/22/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/19/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/18/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/18/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/27/2025
GNRT
NON-FINAL ACTION E-MAILED
01/27/2025
CNRT
NON-FINAL ACTION WRITTEN
01/27/2025
DOCK
ASSIGNED TO EXAMINER
01/14/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/13/2025
NWAP
NEW APPLICATION ENTERED
06/24/2024
Continuous trademark protection
Get notified about every new filing that threatens OXB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.